Amicus Therapeutics Inc

NASDAQ:FOLD   11:25:59 AM EDT
8.78
+0.08 (+0.92%)
Other Pre-Announcement

Amicus Therapeutics Inc - For Full-Year 2022, Anticipates Total Galafold Revenue Of $350 Million To $365 Million

Published: 01/10/2022 12:34 GMT
Amicus Therapeutics Inc (FOLD) - Amicus Therapeutics Inc - for Full-year 2022, Anticipates Total Galafold Revenue of $350 Million to $365 Million.